OCEANSIDE PHARMACEUTICALS Trademark

Trademark Overview

On Tuesday, April 1, 2008, a trademark application was filed for OCEANSIDE PHARMACEUTICALS with the United States Patent and Trademark Office. The USPTO has given the OCEANSIDE PHARMACEUTICALS trademark a serial number of 77437271. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, December 21, 2018. This trademark is owned by Valeant Pharmaceuticals North America. The OCEANSIDE PHARMACEUTICALS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer, neurological and dermatological disorders; pharmaceutical preparations for the treatment of myasthenia gravis, depression, mood/anxiety conditions, solar keratoses and cancer; antidepressants; tranquilizers
oceanside pharmaceuticals

General Information

Serial Number77437271
Word MarkOCEANSIDE PHARMACEUTICALS
Filing DateTuesday, April 1, 2008
Status800 - REGISTERED AND RENEWED
Status DateFriday, December 21, 2018
Registration Number3543028
Registration DateTuesday, December 9, 2008
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 23, 2008

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer, neurological and dermatological disorders; pharmaceutical preparations for the treatment of myasthenia gravis, depression, mood/anxiety conditions, solar keratoses and cancer; antidepressants; tranquilizers
Disclaimer with Predetermined Text"PHARMACEUTICALS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, April 4, 2008
Primary Code005
First Use Anywhere DateSunday, February 29, 2004
First Use In Commerce DateSunday, February 29, 2004

Trademark Owner History

Party NameVALEANT PHARMACEUTICALS NORTH AMERICA LLC
Party Type31 - New Owner After Registration
Legal Entity Type16 - Limited Liability Company
AddressBridgewater, NJ 08807
Party NameValeant Pharmaceuticals North America
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656
Party NameValeant Pharmaceuticals North America
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656
Party NameValeant Pharmaceuticals North America
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressAliso Viejo, CA 92656

Trademark Events

Event DateEvent Description
Wednesday, December 28, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, December 14, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Thursday, June 23, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 9, 2022ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, October 16, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Saturday, October 16, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Saturday, October 16, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Saturday, October 16, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, October 16, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 25, 2020ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, September 8, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, September 8, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, September 8, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 8, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 8, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, December 21, 2018NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, December 21, 2018REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, December 21, 2018REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, December 21, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, December 7, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 7, 2018TEAS SECTION 8 & 9 RECEIVED
Tuesday, October 16, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, October 16, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, December 9, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 21, 2015ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, July 9, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Wednesday, July 9, 2014REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 8, 2014CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, June 19, 2014TEAS SECTION 8 & 15 RECEIVED
Thursday, June 19, 2014TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 20, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, April 27, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, March 23, 2011ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, December 9, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, September 23, 2008PUBLISHED FOR OPPOSITION
Wednesday, September 3, 2008NOTICE OF PUBLICATION
Saturday, August 16, 2008LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, August 16, 2008ASSIGNED TO LIE
Monday, August 11, 2008APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, August 5, 2008TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, August 4, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, August 4, 2008TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, June 28, 2008NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, June 28, 2008NON-FINAL ACTION E-MAILED
Saturday, June 28, 2008NON-FINAL ACTION WRITTEN
Thursday, June 19, 2008ASSIGNED TO EXAMINER
Saturday, April 5, 2008NOTICE OF PSEUDO MARK MAILED
Friday, April 4, 2008NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmaceuticals oceanside pharmaceutical cancer treatment preparations conditions solar tranquilizers anxiety antidepressants keratoses